-The Indian Express Cash in the hands of the poor can transform their lives. With bank accounts and an Aadhaar card for all becoming a reality, it is possible to transfer money directly to the poor and check middlemen who siphon away funds. Cash transfers (CTs) come in many forms. They may be conditional or unconditional, selective or non-selective, targeted or universal. Some types of CT are as susceptible to misuse as...

-The Tribune BARC reports toxic metals in fertilisers as firms avoid costly decontamination process Bathinda (Punjab): The Bhabha Atomic Research Centre (BARC) has found high uranium content in diammonium phosphate and single superphosphate fertilisers that do not undergo the costlier decontamination process during production. The conclusion was reached after testing of soil and fertiliser samples. The Environmental Assessment Division of BARC sent a report on samples of DAP (diammonium phosphate) and single superphosphate...

-FAO Spotlight turns to humanity's silent ally and the risks it faces Rome: Healthy soils are critical for global food production, but we are not paying enough attention to this important "silent ally," FAO Director-General José Graziano da Silva said on the eve of World Soil Day, to be celebrated on 5 December. Healthy soils not only are the foundation for food, fuel, fibre and medical products, but also are essential to...

-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...

-The Telegraph Regulators in several European countries are suspending marketing approval for 25 generic drugs because of concerns over the quality of data from human studies conducted by an Indian contract research company, a French medical safety agency said on Friday. Drug regulators in Belgium, France, Germany and Luxembourg have decided to suspend the marketing authorisation for the generic drugs after they discovered "irregularities" in documents relating to human studies conducted by...